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Abstract:
Adipose tissue has been historically classiﬁed into anabolic white adipose tissue (WAT) and catabolic brown
adipose tissue (BAT). Recent studies have revealed the plasticity ofWAT,wherewhite adipocytes can be induced
into ‘brown-like’ heat-producing adipocytes (BRITE or beige adipocytes). Recruiting and activating BRITE
adipocytes in WAT (so-called ‘browning’) is believed to provide new avenues for the treatment of obesity-
related diseases. A number of hormonal factors have been found to regulate BRITE adipose development and
activity through autocrine, paracrine and systemic mechanisms. In this mini-reviewwewill discuss the impact
of these factors on the browning process, especially those hormonal factors identiﬁed with direct eﬀects on
white adipocytes.
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Introduction
Adipose tissue has historically been classiﬁed into energy-storing white adipose tissue (WAT) and energy-
dissipating brown adipose tissue (BAT) [1]. In contrast to WAT, BAT is a highly oxidative tissue containing
abundant mitochondria that oxidize fatty acids and generate heat. Positron emission tomography (PET) scans
have revealed the existence of canonical BAT in humans [2], however, there is still controversy as to whether
it serves important roles in thermoregulation and energy balance for adult humans [3]. Recent studies have
highlighted the plasticity of WAT, where brown adipocyte-like cells emerge upon sustained cold exposure or
β-adrenergic activation [1], [4]. This process is termed “browning” of WAT [5]. Studies indicate that the newly
formed brown adipocyte-like cells stemming from existingWAT are not traditional myf5+ preadipocytes found
in BAT [6]. A recent study has suggested that BRITE adipocytes contain comparable amounts of uncoupling
protein 1 (UCP1) as fully stimulated brown adipocytes, suggesting that they may have similar thermogenic ca-
pacities [7]. Interestingly, a link between BRITE adipocytes and obesity was also found in humans. The BRITE
adipocytes derived from the preadipocytes of subcutaneous WAT of obese humans contain reduced amounts
of UCP1 [8]. Several lines of evidence even suggested that human BAT ismainly composed of BRITE adipocytes
[9]. The discovery of BRITE adipocytes in humans has also attracted research interest in identiﬁcation of brown-
ing activators for metabolic beneﬁts [10]. These recent ﬁndings raise biomedical interest in the pharmacological
browning of WAT for treating obesity and related metabolic disease in humans [11].
UCP1 expression is a representative marker of canonical brown adipocytes, which is also a distinct marker
to identify the process of ‘browning’ of white adipocytes [7]. The UCP1 protein locates at the inner mitochon-
drial membrane, serving as a channel transporting protons from themitochondrial intermembrane space to the
mitochondrial matrix [12]. This UCP1-mediated proton leak uncouples the respiratory chain, allowing energy
to be released as large amounts of heat instead of generating ATP [13]. UCP1 biosynthesis is largely controlled
at the level of transcription [14]. The 5′ ﬂanking region of the UCP1 gene shares a common genomic structure
in mouse, rat and human: a proximal regulatory region near the transcriptional start site containing CCAAT-
enhancer binding protein (C/EBP)-binding sites and a cyclic adenosine monophosphate (cAMP) regulatory
element [15]. In addition, a highly conserved distal enhancer is present, containing two additional cAMP regu-
latory elements and a complex organization of nuclear receptor binding sites whichmediate the transcriptional
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activation of the UCP1 gene by peroxisome proliferator-activated receptor (PPAR) agonists, thyroid hormones
and retinoids [16]. To date, the majority of known browning agents are found to have the capacity to directly
or indirectly promote UCP1 gene transcription. Although UCP1 expression is a main characteristic of BRITE
cells and commonly used for identifying browning of WAT, other essential events occur during this process,
such as mitochondrial biogenesis and increases in the cellular capacity for glucose and fatty acid uptake and
oxidation [17], [18]. Besides, it is also widely believed that BRITE and brown adipocytes still may have distinct
cell-type-speciﬁc functions that have yet to be studied [7].
The potential for inducing BRITE adipocytes as an anti-obesity strategy has attracted extensive study over
the last decade, which has already enhanced our understanding of the underlyingmechanisms ofWAT brown-
ing. It is suggested that a complex interplay of hormonal factors are involved in the browning process. These
factors include molecules synthesized locally within adipose tissue as well as hormones released by other
metabolically active organs. In this mini-review, an overview of the current understanding of the impact of
these factors on the browning process will be summarized.
Norepinephrine – the keymolecular control ofWATbrowning
In canonical brown adipocytes, themost striking characteristic is the capacity to generate heat by non-shivering
adaptive thermogenesis [19]. UCP1 is responsible for this process [20]. The most signiﬁcant and the most stud-
ied activator of adaptive thermogenesis is norepinephrine. It is released from sympathetic nerve endings and
acts on β-adrenergic receptors on the surface of brown adipocytes to elicit a myriad of thermogenic events,
including induction of UCP1 transcription [21]; enhancing intracellular lipolysis and mitochondrial oxidation;
and stimulation of circulating triglyceride uptake [22]. The β3-adrenergic receptor is the most important adren-
ergic receptor involved in BAT activation, although both β1- and β2-adrenergic receptor activations are able to
compensate for the loss of the β3-adrenergic receptor in knock-out mice models for BAT activation [23].
Along with its critical roles in BAT activation and recruitment, norepinephrine also occupies a central
role in WAT browning. Noradrenergic regulation of WAT browning is considered to act mainly through the
β3-adrenergic receptor. Indeed, some studies indicated that the β3-adrenergic receptor may play an indispens-
able role in WAT browning, as the loss of the β3-adrenergic receptor in knock-out mice almost abolishes the
cold-induced browning inWAT [23], [24]. However, a recent study has revealed that the β3-adrenergic receptor
is not required for browning of WAT due to cold exposure [25]. The inconsistency in these ﬁndings may be
attributed to the diﬀerent mouse strains used in the studies. Regardless of the receptor requirements, the pro-
moting eﬀect of noradrenergic stimulation on browning was also demonstrated in humans. In a clinical study,
the subcutaneous WAT of severely burned patients was found to adopt a BAT-like phenotype after prolonged
and severe adrenergic stress, with increasedmultilocular UCP1-positive adipocytes, mitochondrial density and
respiratory leak capacity being observed, which demonstrates that human subcutaneous WAT also can trans-
form into energy-dissipating tissue [26]. Due to the potential importance of the β3-adrenergic receptor in WAT
browning, agonists to β3-adrenergic receptors are promising therapeutic drug candidates to curb obesity. Al-
though a number of β3-adrenergic receptor agonists have failed in clinical trials due to signiﬁcant side eﬀects, a
recent report claimed that the mirabegron, a β3-adrenergic stimulator approved for the treatment of overactive
bladder, can activate BAT in healthy humans [27]; however, its therapeutic utility in obese or diabetic humans
remains to be established.
Thyroid hormones in the control ofWATbrowning
Both BAT andWAT express a wide range of nuclear receptors that have the potential to regulate the expression
of genes involved in brown/BRITE adipocyte biology [28]. Thyroid hormones act through the thyroid receptor
and are considered non-sympathetic activators of BAT. Animal studies revealed that hypothyroidmice had sig-
niﬁcantly decreased and hyperthyroid mice had signiﬁcantly increased interscapular BAT activities compared
to euthyroid controls [29]. Thyroid hormones can both directly and indirectly stimulateUCP1 gene transcription
in BAT. The thyroid hormones can enhance sympathetic nervous system (SNS) activity through the induction
of AMP-kinase in the hypothalamus to activate BAT [30]. In addition, the thyroid response elements located in
the distal enhancer of the UCP1 gene also allow the binding of the thyroid receptor to regulate UCP1 expres-
sion [31]. Furthermore, there is extensive crosstalk between the norepinephrine and thyroid hormone actions in
controlling BAT activities. UCP1 levels vary with triiodothyronine (T3) concentration in BAT, which can be con-
verted from thyroxine (T4) by type II iodothyronine 5′-deiodinase (DIO2). In BAT, DIO2 can be activated by the
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SNS and, therefore, adrenergic signals can be ampliﬁed by thyroid hormones to reach a maximal thermogenic
response [32].
Thyroid hormones also induce the thermogenic program in WAT, leading to the browning of white fat de-
pots with a restoration of cold tolerance in cold-intolerant mice [33], [34]. The thermogenic genes [UCP1, PR
domain containing 16 (PRDM16), ﬁbroblast growth factor 21 (FGF21), cell death-inducing DFFA-like eﬀector
A (Cidea), PPARγ coactivator 1α (PGC-1α)] and BRITE adipocyte markers [Cd137, transmembrane protein 26
(Tmem26)]were signiﬁcantly increased in epididymalWAT inhyperthyroidmice compared to hypothyroid and
euthyroid mice [29], [33]. Thyroid receptor agonist-induced browning was also observed in white adipocytes
in vitro, indicating that thyroid hormones may directly mediate browning in a cell-autonomous manner [34].
Notably, the DIO2 expression level in mature white adipocytes is much lower than in brown adipocytes, sug-
gesting that thyroid hormones may promote BAT activation andWAT browning through diﬀerent mechanisms
[35].
Recent data also reported that liver X receptor β (LXRβ) controls thyroid hormone feedback in the brain
and regulates browning of subcutaneous WAT. LXRs, especially LXRβ, serve to repress the browning pro-
cess of subcutaneous WAT. The knock-out of LXRs increases the production of thyroid hormones through
the hypothalamic-pituitary-thyroid axis. Consequently, the circulating thyroid hormone level and browning
of WAT are upregulated. As LXR is the receptor for cholesterol and fatty acids, these ﬁndings demonstrate a
possible mechanism of thyroid hormones regulating energy expenditure in response to cholesterol and fatty
acid metabolism [36].
FGF21 and irisin – signals from shivering andnon-shivering thermogenesis toWAT
In response to cold stimulation, the bodywill try to maintain body temperature homeostasis via both shivering
(skeletal muscles) and non-shivering (BAT activation) thermogenesis. Interestingly, it was also found that cold
exposure also increases secretion of the myokine irisin and the brown adipokine FGF21 from muscle and BAT,
respectively. Both irisin and FGF21 promote browning of white adipocytes in adaptive thermogenesis [37],
[38]. These eﬀects represent connections between muscle, BAT and WAT, orchestrating cold-induced adaptive
thermogenesis.
Irisin is a cleaved version of ﬁbronectin type III domain-containing protein (FNDC5), which is a target gene
regulated by PGC-1α. As exercise increases expression of PGC-1α in muscle, FNDC5 was ﬁrst identiﬁed as an
exercise-induced activator of browning. Primary subcutaneous white adipocytes treated with FNDC5 show
a signiﬁcant increase in UCP1 mRNA [38]. Further studies suggested that FNDC5 will be cleaved at the C-
terminal, glycosylated and secreted in the form of irisin. Accumulating evidence indicates that irisin is the
active form of FNDC5 in the circulation, playing an important role in converting white adipocytes to BRITE
adipocytes [38], [39], [40]. The secretion of irisin correlates with shivering intensity, suggesting that irisin may
amplify heat production by passing on the signals from shivering thermogenesis to non-shivering thermogene-
sis [38]. This eﬀectmay bemediated by the irisin-induced phosphorylation of the p38mitogen-activated protein
kinase (p38 MAPK) and the extracellular signal-related kinase (ERK) signaling pathways in white adipocytes
[39]. Recently, it was further demonstrated that irisin has a dual role in pre- and mature white adipocytes.
Irisin only promotes “browning” of mature white adipocytes, whereas it inhibits adipogenic diﬀerentiation of
preadipocytes [40].
Similarly, FGF21, a cytokine with the capacity for WAT browning, was also signiﬁcantly augmented after
cold stimulation. Cold-stimulation mainly increases FGF21 secretion from BAT [41]. Experimental studies have
demonstrated that the central eﬀects of FGF21 on sympathetic activation and the direct eﬀects mediated by the
FGF receptor on white adipocytes both contribute to the browning of WAT [37], [42], [43]. Additionally, FGF21
also activates BAT in a cell-autonomous way [37]. FGF21 regulates this process, at least in part, by enhancing
adipose tissue PGC-1α protein levels independently of mRNA expression [37]. FGF21, as well as its analogs,
have shownanti-diabetic and anti-obesogenic eﬀects in rodentmodels [44], [45], [46].Moreover, FGF21-deﬁcient
mice display an impaired cold response in inguinal WAT but not in canonical BAT, indicating an important role
in metabolic regulation. However, a recent study indicates that FGF21 is still eﬀicacious in UCP1-null mice,
suggesting that FGF21’s anti-diabetic and anti-obesogenic eﬀects are independent of thermogenesis in brown
and BRITE adipocytes [47].
Notably, adipose-derived FGF21 expression is not only regulated by cold stimulation. Nutritional signals
and physical activity also play important roles in the regulation of FGF21 expression [48], [49], suggesting that
FGF21may be an important molecular regulator of thermogenesis in response to environmental metabolic con-
ditions. Furthermore, FGF21 is also released by the liver and muscle [50], [51], [52]. FGF21 secreted by the liver
directly activates BAT heat production as well as browning of WAT depots, hinting that this liver-to-adipose
tissue regulatory loop also contributes to the thermogenic program [50].
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Recently, another exercise- and cold-induced myokine hormone (meteorin-like) was discovered. Increasing
circulating levels of meteorin-like stimulates the expression of BRITE adipocyte marker genes associated with
thermogenesis [53]. In light of these ﬁndings, cold-induced hormonal changes may be the potent and relevant
physiological regulators of thermogenesis.
E昀�fect of insulin and glucagon onWATbrowning
Insulin is the most important regulator of glucose metabolism, with its major role in promoting the absorp-
tion of glucose from the circulation into adipose tissue, liver and skeletal muscle. In addition, insulin is also
crucial for the development of canonical brown adipocytes as well as for the development of inducible BRITE
adipocytes. Insulin deﬁciency was found to impair the diﬀerentiation of BRITE adipocytes, although this in-
hibitory eﬀect could be overcome by stronger stimuli such as adrenergic activation [54]. Insulin produces its
eﬀect on browning through its action on pro-opiomelanocortin (POMC) neurons together with leptin [55].
Interestingly, although glucagon plays the opposing role to insulin in glucose metabolism, it has also been
recognized as a strong BAT activator in rodents [56]. In addition, glucagon supplementation was found to
induce a signiﬁcant increase in plasma FGF21 in glucagon-depletedmice via enhanced hepatic FGF21 secretion
[57]. As it has been demonstrated that increased circulating FGF21 promotes the browning of WAT, glucagon
may alsomediate the browning process indirectly. Latest evidence also indicates that glucagon increases energy
expenditure by a similar magnitude compared with cold activation, but independently of BAT thermogenesis,
also hinting the possible eﬀect of glucagon on WAT browning [58].
Gastrointestinal hormones in the control of browning
The gastrointestinal tract is the organ that digests ingested food and absorbs energy and nutrients; therefore,
it can directly sense the ﬂuctuation of nutrient status and secrete a range of hormones to maintain energy
homeostasis. Many gastrointestinal hormones can send hunger or satiety signals to the central nervous system
(CNS) and SNS via the gut-brain axis and further regulate feeding behavior and metabolic processes involving
the activation of BAT and the browning ofWAT. In general, anorexigenic gut hormones normally stimulate BAT
while orexigenic gut hormones often inhibit BAT activity.
For example, glucagon-like peptide-1 (GLP-1), an anorexigenic polypeptide, is able to regulate BAT activity
by hypothalamic action. Although the principal eﬀect of GLP-1 is to stimulate insulin secretion and to reduce
glucagon secretion, studies also demonstrated the control of GLP-1 on BAT thermogenesis through the GLP-1
receptor in the hypothalamus, which is independent of nutrient intake and insulin responsiveness but corre-
lated with increased activity of sympathetic ﬁbers innervating BAT [59], [60]. Furthermore, central injection of
a GLP-1R agonist also stimulates WAT browning through the hypothalamic AMPK. The mechanism control-
ling these actions is located in the hypothalamic ventromedial nucleus (the ventromedial hypothalamus, VMH)
[60].
Similarly, several other anorexigenic hormoneswere found to strengthen BAT activity via the SNS, although
there is no clear evidence concerning their eﬀect on browning. For example, amylin, an anorexigenic peptide
secreted into the circulation by pancreatic β-cells, was also found to act in the CNS to increase sympathetic nerve
activity to BAT and elicit a thermogenic response [61]. Injection of anorexigenic cholecystokinin (CCK) into the
third ventricle or into selected hypothalamic sites was also found to increase interscapular BAT sympathetic
nerve activity, BAT temperature and expired CO2 in anesthetized rats. Bilateral cervical vagotomy prevented
these CCK-evoked eﬀects, indicating that peripheral CCK acts via vagal aﬀerents to increase BAT activity [62],
[63].
In contrast, ghrelin, as an orexigenic gastrointestinal hormone, stimulates the appetite and increases food
motivation [64], [65]. Ghrelin acts on the hypothalamus by stimulating secretion of agouti-related protein
(AgRP) [66]. Centrally administered ghrelin into the third cerebral ventricle suppresses sympathetic nerve ac-
tivity innervating BAT and decreases BAT temperature in rats [67].
Interestingly, evidence also emerged that certain anorectic and orexigenic hormones may counteract each
other’s eﬀects on SNS activation. For example, galanin, which stimulates food intake, inhibited sympathetic
nerve ﬁring rate to interscapular BAT. In contrast, enterostatin, an anorectic pentapeptide formed in the lumen
of the small intestine from the pancreatic procolipase under the inﬂuence of digestive enzymes, was reported
to transiently increase the sympathetic ﬁring rate of nerves innervating BAT [68]. Importantly, the response to
enterostatin was determined by diet. On a high fat diet, enterostatin induced a large and sustained response,
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whereas a minimal short-lived response was observed on a chow diet. This study supports the hypothesis that
gastrointestinal hormone-regulated food intake and SNS activity have a reciprocal relationship.
There are additional notable metabolic substances with roles in the regulation of browning. For example,
bile acids also have metabolic actions in the body resembling those of hormones. They are an important class
of lipid-signaling molecules synthesized in the liver. In addition to their major function as detergents facilitat-
ing gut lipid digestion, they have actions in other organs including adipose tissues through the speciﬁc bile
acid receptors farnesoid X receptor-α (FXRα), a nuclear receptor activated by bile acids, and the G-protein-
coupled receptor TGR5. The bile acid chenodeoxycholic acid (CDCA) has been found to activate BAT themo-
genesis and protect against obesity [69]. Importantly, the bile acid-mediated protection from obesity is lost
in UCP1-knockout mice [70], supporting that the eﬀect is through thermogenesis. Furthermore, activation of
TGR5 in brown adipocytes by either the bile acids CDCA or lithocholic acid (LCA) or a selective ligand (CpdA)
stimulated respiratory uncoupling [71]. As with β-adrenergic receptors, TGR5 couples to adenylate cyclase
with cAMP-dependent signaling likely to activate the same processes that elevate energy expenditure. For the
browning of WAT, research to date indicates eﬀects of bile acids through FXR. It was reported that selectively
activating intestinal FXR by a gut-restricted FXR agonist robustly induced enteric intestinal endocrine hormone
ﬁbroblast growth factor 15 (FGF15), leading to reduced diet-inducedweight gain, body-wide inﬂammation and
hepatic glucose production, as well as enhanced thermogenesis and browning of WAT [72].
Taken together, gastrointestinal hormones play crucial roles inWAT browning in response to the ﬂuctuation
of dietary nutrients or the energy state in the body.
Hypothalamic hormones in the control ofWATbrowning
Great eﬀorts have beenmade to elucidate the neural circuits responsible for governing the sympathetic outﬂow
to BAT. Current evidence indicates that cold signals sensed by thermoreceptors, together with other peripheral
signals such as hormones and nutrients, are integrated in the brain, especially the arcuate nucleus (ARC) of the
hypothalamus. Two populations of neurons in the ARC function in opposing ways to express orexigenic AgR-
P/neuropeptide Y (NPY) and anorexigenic POMC, respectively. The second-order neurons located largely in
the lateral hypothalamus (LH) and the paraventricular nucleus (PVN) of the hypothalamus receive projections
from theARC aswell as direct inputs fromperipheral signals. Togetherwith theARC, the LH and PVN function
as a metabolic integrator and regulator by projecting to high-order neurons in the CNS and secreting various
neuropeptides such as orexin, melanin-concentrating hormone (MCH), cocaine- and amphetamine-regulated
transcript (CART) and corticotropin-releasing hormone (CRH). Indeed, both BAT and WAT are extensively
innervated by sympathetic ﬁbers that can be tracked back to the hypothalamus [73]. The details of this neu-
roanatomical and neurotransmitter/hormonal organization of the core thermoregulatory network have been
systematically reviewed previously [74].
Although it has not been conﬁrmed that these neuronal circuits play the same role in the control of WAT
browning, it is reasonable to hypothesize that they exert their functions in a similar way. Several studies have
revealed that activation of AgRP neurons in the hypothalamus suppresses the browning process [75], while
stimulation of POMC neurons promotes WAT browning [55]. These two opposing eﬀects demonstrate that the
AgRP/NPY and POMC neurons in the ARC could sense the body’s energy state and regulate whole-body
metabolism, including the browning of fat. Additional studies also support that hypothalamic hormones play
crucial roles in the regulation of browning, depending on energy states. For example, neuron and adipocyte co-
culture studies indicate that NPY secreted from sympathetic neurons inhibit β-adrenergic-mediated signaling
[76]. Viral-mediated knockdown of orexigenic NPY in the dorsomedial hypothalamus (DMH) promotes BAT
activation and WAT browning through the SNS [77].
Oxytocin is recognized as an anorexigenic neuropeptide, which has eﬀects including reducing gastric emp-
tying and GI transit, as well as by suppressing the feeding reward circuit [78], [79]. Knockout mice for oxytocin
or its receptor (OXTR)were shown to develop late-onset obesity [80], without alterations in food intake, indicat-
ing that oxytocin also controls metabolic homeostasis by modulating energy expenditure. Oxytocin treatment
of db/db mice resulted in a decrease in adipocyte size, reduction in fat pad mass as well as induction of BRITE
adipocytes in WAT [81].
CRH is a peptide hormone and neurotransmitter involved in stress response. The ability of CRH to stimu-
late BAT thermogenesis has been extensively studied. Central injection of CRH leads to the activation of BAT
thermogenesis in rats [82]. CRH functions mainly through two G protein-coupled receptors: CRH receptors
types 1 (CRH-R1) and 2 (CRH-R2) [83]. Both receptors have been identiﬁed in brown adipocytes as well as
in white adipocytes. Using the T37i cell in vitro model, CRH was found to promote brown adipocyte diﬀer-
entiation through inhibition of Fyn kinase. Pharmacological inhibition of Fyn kinase also enhanced brown
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adipocyte diﬀerentiation [82]. Recently, greater insight into the underlying mechanisms by which CRH reg-
ulates adipocyte diﬀerentiation was revealed, with the balance between CRH-R1 and CRH-R2 important in
the control of adipocyte plasticity. Activation of CRH-R2 or inhibition of CRH-R1 in 3T3-L1 preadipocytes
was able to induce morphological and biochemical characteristics of BRITE adipocytes [84]. An in vivo study
also supported the corticotrophin-releasing factor/urocortin system in regulating browning through paracrine
mechanisms inmice. Increased CRH-R2 activity in adipocytes induces browning ofWAT, diﬀerentiation of BAT
and is associated with a favorable metabolic phenotype in mice lacking CRH-R1 [85]. Furthermore, CRH also
aﬀects energy metabolism via its cross-talk with other hormones. For example, CRHworks downstream of the
PVN to increase secretion of the neurotransmitter CART, which also induces the expression of UCP1 in both
BAT and WAT [86]. CRH was also found to be a component of the pathway of leptin-dependent regulation of
UCP1 expression [87]. It has been recognized that chronic stress may be a contributor to the increased risk for
obesity; therefore, these ﬁndings indicate that CRH is a key hormone which mediates the links between stress
and energy metabolism.
Numerous studies in a variety of species, including humans, showed that growth hormone (GH) levels are
negatively correlated with adipose tissue mass. Adults and children with GH deﬁciency have increased fat
mass, while treatment of GH-deﬁcient patients with recombinant human GH decreases fat mass [88], [89], [90].
In mouse models, loss of the GH receptor or treatment with a GH antagonist increases interscapular BATmass
and UCP1 expression [91], [92], while a decrease in interscapular BAT was found after bovine GH overexpres-
sion with decreased UCP1 expression [92]. Similarly, the knockout of GHR or GH antagonist treatment also
increased the UCP1-expressing adipocytes within subcutaneous WAT depots, suggesting that GH also aﬀects
the browning process [92]. Knockout of GH-releasing hormone, a hormone required for GH secretion in mice,
also leads to browning of WAT and elevated expression of UCP1 [93].
An enriched environment was also proved to promote browning via induction of hypothalamic brain-
derived neurotrophic factor (BDNF) expression. Hypothalamic BDNF has been shown to increase thermogene-
sis and energy expenditure by acting on neurons in the PVN and VMH [94], [95], which further upregulates the
brown adipocyte fate-determining gene PRDM16, speciﬁc marker UCP1 and genes involved in thermogenesis
and β-adrenergic signaling in mouseWAT. These ﬁndings suggested a mechanismwhereby a response to envi-
ronmental stimuli leads to selective sympathoneural modulation of WAT to induce ‘browning’ and increased
energy dissipation [96].
Taken together, the hypothalamus, as an important organ responsible for maintaining homeostasis (includ-
ing body temperature and body weight), can integrate signals received from the body, to then make the appro-
priate changes in hormone secretion to activate or inhibit thermogenesis and browning of WAT.
Adipose-derivedhormones in the control of browning
WAT is not only a site of energy storage, but is also an endocrine organ that secretes a wide range of adipokines
[97]. Therefore, WAT-derived hormones have the potential to regulate the browning process through autocrine
mechanisms. Leptin represents a goodmodel of howWAT sends signals related to energy status to the CNS (hy-
pothalamus) to impact on whole-body metabolism and also directly aﬀects the browning of white adipocytes.
Leptin injection was demonstrated to reduce the body weight with a 4–5-fold increase in UCP1 expression in
both interscapular BAT and retroperitoneal WAT in ob/ob mice [98]. This enhancement of UCP1 expression
in BAT seems to be through a β3-adrenoceptor independent mechanism [99]. A leptin-knockout mouse model
conﬁrmed that leptin stimulates UCP1 expression as UCP1 expression was decreased in BAT, muscle, inguinal
and gonadal fat [98].
Bone morphogenetic protein 4 (BMP-4) is another important adipose-derived factor that promotes brown-
ing. Transgenic expression of BMP-4 stimulates the conversion ofmesenchymal precursors speciﬁcally to BRITE
adipocytes, suggesting an important role for BMP-4 in browning [100]. β3-Adrenergic receptor activation also
augments BMP-4 expression in an organ-autonomous manner in adipocytes [100]. BMP-4 belongs to the BMP
family which inﬂuences the diﬀerentiation of mesenchymal stem cells. Several other members of this protein
family are also identiﬁed as key regulators of canonical BAT diﬀerentiation and activation. For example, BMP-7
promotes the diﬀerentiation of brown preadipocytes by inducing the expression of PRDM16 and PPARγ [101],
while BMP-8b directly regulates thermogenesis in mature brown adipocytes by increasing their responsive-
ness to noradrenaline and upregulating intracellular lipase activity via the protein kinase A (PKA)-MAPK
pathway [102]. The activity of BMPs in adipose tissue is counteracted by gremlin-1 which is secreted by WAT
preadipocytes [103]. However, the precise roles of the BMP family members and their regulators in browning
still needs further validation.
6
Authenticated | m.christian@warwick.ac.uk author's copy
Download Date | 7/24/17 11:17 AM
A
ut
om
at
ic
al
ly
ge
ne
ra
te
d
ro
ug
h
PD
F
by
Pr
oo
fC
he
ck
fr
om
R
iv
er
Va
lle
y
Te
ch
no
lo
gi
es
Lt
d
DEGRUYTER Hu and Christian
In response to β3­adrenergic receptor activation, prostaglandins are also produced in an organ ­au-
tonomous manner in WAT to promote browning. Prostaglandin synthesis in WAT is mainly controlled by
prostaglandin-endoperoxide synthase (PTGS) activity [104], which could be activated by cold exposure.
Thereby, prostaglandin levelswill be augmented after cold stimulation,which further stimulates the expression
of PGC­1α in WAT­ resident mesenchymal progenitors [105].
During the activation of browning, WAT undergoes a series of morphological changes to adapt to energy
expenditure and heat production [106]. For example, cold stimulates the branching and recruitment of sympa-
thetic nerves aswell as the sprouting and growth of blood vessels during the browning ofWAT [107]. Therefore,
hormones regulating these events also regulate browning [108], [109]. For example, VEGF secreted by adipose
tissue, a hormone with an angiogenic eﬀect, also enhances the recruitment of brown and BRITE adipocytes
[110], [111], suggesting a complexity in signaling pathways involved in the browning process. Another EFG-
like factor, neuregulin 4, expressed by adipocytes, is known to be secreted by brown adipocytes and has the
capacity to promote neuronal innervation [1]. As neuregulin 4 is upregulated in WAT in response to cold ex-
posure, it may have an important role in promoting innervation in this tissue during browning.
Recently, it was also revealed that white adipocytes, but not brown adipocytes, could directly sense cold
stimulation to activate thermogenesis and UCP1 expression. These ﬁndings provide an unusual insight into
the role of WAT in its browning, as well as an alternative way to target non-shivering thermogenesis [112]. The
autocrine eﬀects of WAT-derived hormones may play important roles in this process.
Hormones fromother peripheral organs in the regulation ofWATbrowning
Catecholamines play important roles in regulating browning. Interestingly, besides sympathetic nerve
synapses, alternatively activated macrophages (M2) in adipose tissue have been reported to also secrete
norepinephrine for BAT activation [113]. The adrenal gland is also a key organ releasing epinephrine
and norepinephrine into the circulation for systemic eﬀects on multiple organs including adipose tissue.
Furthermore, several observational studies demonstrated that pheochromocytoma patients have increased
F18-ﬂuorodeoxyglucose (FDG) uptake activity in BAT, which is diminished following surgical treatment [114],
[115]. Hence, these catecholamine-releasing cells and organsmay also regulate BAT activity andWATbrowning
through adrenergic receptors.
Recently, heart-derived hormones such as natriuretic peptides (NPs) were also found to enhance BAT ther-
mogenesis as well as WAT browning. Treatment with brain NP increases UCP1 expression in both BAT and
WAT. This eﬀect wasmainlymediated byNP receptors through the activation of p38MAPK [116]. Mice lacking
the NP clearance receptor, the negative regulator of nitric oxide (NO) activity, also showed enhanced brown-
ing of WAT. Recently, cardiotrophin-1, a heart-derived cytokine, was also found to improve glucose and lipid
metabolism, with enhanced mitochondrial biogenesis and browning phenotype in WAT [117]. A summary of
the hormonal factors implicated in the control of the browning of white adipose tissue is illustrated in Figure
1.
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Figure 1: Hormonal factors in the control of browning of white adipose tissue.
A number of hormonal factors secreted from diﬀerent organs and tissues have been found to regulate the browning of
white adipose tissue through systemic, autocrine and paracrine mechanisms. AgRP, agouti-related protein; BAT, brown
adipose tissue; BMP-4, bone morphogenetic protein 4; BNDF, brain-derived neurotrophic factor; CCK, cholecystokinin;
CRH, corticotropin-releasing hormone; CRH-R1, corticotropin-releasing hormone receptor 1; CRH-R2, corticotropin-
releasing hormone receptor 2; DIO2, type II iodothyronine 5′-deiodinase; FGF15, ﬁbroblast growth factor 15; FGF21, ﬁ-
broblast growth factor 21; GH, growth hormone; GI, gastrointestinal tract; GLP-1, glucagon-like peptide-1; M2, alterna-
tively activated macrophages; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; T4, thyroxine; T3, triiodothyronine;
VEGF, vascular endothelial growth factor; WAT, white adipose tissue.
With the discovery of these novel links between other organs and WAT during the browning process, the
comprehensive regulation network for thermogenesis will further be elucidated in future investigations.
Conclusion
In summary, given the scarcity of BAT in human adults, pharmacological and nutritional induction of BRITE
cells is a promising anti-obesity and anti-diabetic strategy to treat metabolic disorders. Indeed, the interest to
reveal hormonal pathways to trigger WAT browning has been ignited in the last decade. As the β-adrenergic
pathway appears to be the most important mediator of BRITE induction and common to many of the diﬀer-
ent browning activators, it is a key focus of therapeutic interventions. Several strategies such as upregulating
sympathetic input into WAT, increasing sensitivity and/or the amount of adrenergic receptors in WAT and
manipulating key transcription factors in the browning process (e.g. PPARγ) have been explored as pragmatic
approaches to induce browning. For example, human studies have shown that highly selective β3-selective
adrenergic agonists such as mirabegron and L-796568 may increase energy expenditure with minor or no car-
diovascular side eﬀects in overweight men [27], [118], [119]. Furthermore, re-examining the browning eﬀects
of already approved drugs seems to also be a viable option. For example, exenatide and sildenaﬁl, originally
designed for type 2 diabetes and erectile dysfunction treatment, respectively, are subject to testing their brown-
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ing eﬀects in phase 4 clinical trials (http://clinicaltrials.gov/show/NCT02524184 and http://clinicaltrials.gov-
/show/NCT03002675).
Additionally, identifying nutritional factors with positive eﬀects on WAT browning also seems to be an
attractive approach. Based on current evidence, hormonal factors also play important roles in mediating the
browning eﬀects of many nutritional factors. For example, capsaicin and capsinoids with well-documented
WAT browning properties can activate the transient receptor potential cation channel, subfamily V, member
1 (TRPV1) to stimulate Ca2+ inﬂux, which then activates the Ca2+/calmodulin-dependent protein kinase II
and AMP-activated kinase, with the consequent stimulation of sirtuin-1-dependent deacetylation of PPARγ
and PRDM16 to increase synthesis of BMP8b and UCP1 [120], [121]. Similarly, fucoxanthin and ﬁsh oil [rich
in ω3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid and docosahexaenoic acid] can also induce
UCP1 expression inWATvia upregulating β3-adrenergic receptor expression and consequently enhancingWAT
sensitivity to adrenergic stimulation in adipocytes [94], [95], [122].
Notably, the levels ofWAT browningmay also represent whole-body energy status instead of being decided
only byhormonal pathways. For instance, although exercise has been reported to increase browning ofWATand
increase energy expenditure [38], a study in athletes and non-athletes showed that BAT volume and activity in
athletes tended to be lower. This demonstrates that brown fat may undergo adaptive reductions in cases where
there is an energy deﬁcit, such aswith chronic exercise [123]. In conclusion, due to the high degree of integration
and redundancy of metabolic regulation by numerous hormones, elucidating the signaling pathway networks
controlling BRITE cell recruitment is still a complex task but crucial to lay the foundation for the exploration of
novel molecules promoting browning and development of a new generation of anti-obesity drugs.
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